This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Eternygen raises €8mm in Series A round; includes investment from partner Evotec
10 Jan 2017
Eternygen GMBH (metabolic disease focused biopharma) raised €8mm ($8.3mm) in its Series A financing round led by Epidarex Capital, along with VC Founds Technologie (managed by IBB Beteiligungsgesellschaft), and two family offices. The round also includes participation from partner Evotec AG.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?